복막투석은 정상적인 생리적 상태의 장애를 야기하는 체내의 독성물질을 치료적으로 제거하는 임상적 방법이다. 본 연구에서는 신부전으로 내원한 환자에게 복막투석을 적용한 20증례의 임상적 결과와 합병증을 후향적으로 평가하였다. 복막투석을 실시하는 동안 적혈구수, 혈구용적, 신기능과 관련된 혈액 화학적 수치 및 전해질 등의 혈액학적 분석과 합병증, 임상적 결과 등을 기록하였다. 복막투석의 결과로 19마리의 개에서 혈중 요소 질산 농도가 유의하게 감소하였고 (p<0.05), 17마리의 개에서 혈중 크레아티닌의 농도가 유의하게 감소하였다 (p<0.05). 복막투석의 부작용으로는 저알부민혈증(12/20, 60%), 빈혈(10/20, 50%), 투석액의 피하 누출(9/20, 45%), 세균성 복막염 (6/20, 30%), 투석액의 저류 (5/20, 25%)와 사지의 부종(4/20, 20%)이 나타났다. 본 증례고찰을 통하여 복막투석은 신부전(특히 급성기)에 이환된 개에서 질소혈증을 개선하는데 효과적임을 알 수 있었다.
복막투석은 정상적인 생리적 상태의 장애를 야기하는 체내의 독성물질을 치료적으로 제거하는 임상적 방법이다. 본 연구에서는 신부전으로 내원한 환자에게 복막투석을 적용한 20증례의 임상적 결과와 합병증을 후향적으로 평가하였다. 복막투석을 실시하는 동안 적혈구수, 혈구용적, 신기능과 관련된 혈액 화학적 수치 및 전해질 등의 혈액학적 분석과 합병증, 임상적 결과 등을 기록하였다. 복막투석의 결과로 19마리의 개에서 혈중 요소 질산 농도가 유의하게 감소하였고 (p<0.05), 17마리의 개에서 혈중 크레아티닌의 농도가 유의하게 감소하였다 (p<0.05). 복막투석의 부작용으로는 저알부민혈증(12/20, 60%), 빈혈(10/20, 50%), 투석액의 피하 누출(9/20, 45%), 세균성 복막염 (6/20, 30%), 투석액의 저류 (5/20, 25%)와 사지의 부종(4/20, 20%)이 나타났다. 본 증례고찰을 통하여 복막투석은 신부전(특히 급성기)에 이환된 개에서 질소혈증을 개선하는데 효과적임을 알 수 있었다.
Peritoneal dialysis (PD) is a clinical technique that therapeutically removes toxic solutes from body fluids and normalizes endogenous solutes whose aberrant concentrations disrupt normal physiology. This study retrospectively evaluated clinical outcomes and complications of PD in 20 dogs with renal...
Peritoneal dialysis (PD) is a clinical technique that therapeutically removes toxic solutes from body fluids and normalizes endogenous solutes whose aberrant concentrations disrupt normal physiology. This study retrospectively evaluated clinical outcomes and complications of PD in 20 dogs with renal failure. Blood works (total count of red blood cells (RBC), packed cell volume (PCV), the serum biochemical, and electrolyte values related to renal insufficiency) and complications associated with peritoneal dialysis, and clinical outcomes were recorded before and after PD. Additionally, creatinine reduction ratio (CRR) and urea nitrogen reduction ratio (URR) were calculated for evaluating the efficacy of PD. PD resulted in a significant (p < 0.05) reduction in blood urea nitrogen (BUN) concentration in 19 dogs, while a significant (p < 0.05) reduction in creatinine concentration in 17 dogs. The complications of PD were hypoalbuminemia (12/20, 60%), anemia (10/20, 50%), subcutaneous dialysate leakage (9/20, 45%), bacterial peritonitis (6/20, 30%), dialysate retention (5/20, 25%) and limb edema (4/20, 20%). This study demonstrated that PD was effective in reducing the magnitude of azotemia in dogs with renal failure especially in acute phase, although the complication rate was high but manageable.
Peritoneal dialysis (PD) is a clinical technique that therapeutically removes toxic solutes from body fluids and normalizes endogenous solutes whose aberrant concentrations disrupt normal physiology. This study retrospectively evaluated clinical outcomes and complications of PD in 20 dogs with renal failure. Blood works (total count of red blood cells (RBC), packed cell volume (PCV), the serum biochemical, and electrolyte values related to renal insufficiency) and complications associated with peritoneal dialysis, and clinical outcomes were recorded before and after PD. Additionally, creatinine reduction ratio (CRR) and urea nitrogen reduction ratio (URR) were calculated for evaluating the efficacy of PD. PD resulted in a significant (p < 0.05) reduction in blood urea nitrogen (BUN) concentration in 19 dogs, while a significant (p < 0.05) reduction in creatinine concentration in 17 dogs. The complications of PD were hypoalbuminemia (12/20, 60%), anemia (10/20, 50%), subcutaneous dialysate leakage (9/20, 45%), bacterial peritonitis (6/20, 30%), dialysate retention (5/20, 25%) and limb edema (4/20, 20%). This study demonstrated that PD was effective in reducing the magnitude of azotemia in dogs with renal failure especially in acute phase, although the complication rate was high but manageable.
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
문제 정의
Table 4. Complications associated with peritoneal dialysis in dogs enrolled in this study.
The purpose of this retrospective study was to evaluate the clinical outcomes and complications of PD in dogs with renal failure.
가설 설정
C: A purse-string suture was placed to secure the catheter. D: A tape butterfly was added to secure the catheter to the skin in the lateral abdomen.
제안 방법
Analysis of the pre- and post-dialysis BUN and creatinine concentrations for each patient was performed. Mean concentrations of pre-dialysis creatinine and BUN were 8.
Blood cell count, blood chemistry and plasma electrolyte analysis were performed prior to initiation of PD, with blood cell analyzer (FORCYTETM, Oxford Science Inc., USA), serum biochemistry analyzer (SPOTCHETM‚ EZ SP-4430, Arkray factory Inc., Japan) and I-Stat® (Heska, USA), respectively.
대상 데이터
Twenty dogs (11 males and 9 females) with renal failure were enrolled in this study. The patient information enrolled in this study and etiologies of each case were summarized in Table 1.
데이터처리
The mean and SD were calculated for each of these values. Pre- and post-dialysis BUN and creatinine concentrations for each patient were analyzed, using the Wilcoxon signed rank test. Paired student t-test was performed on preand post-dialysis BUN and creatinine concentrations.
성능/효과
In conclusion, this study clearly demonstrated that PD was effective in reducing the magnitude of azotemia in dogs with acute and chronic renal failure, although the complication rate was high but manageable. Therefore PD is more realistic treatment option for dogs with unresponsive renal failure in Korean veterinary practice.
Of those animals with acute renal failure, hemoconcentration (2/12, 16.7%), anemia (4/12, 33.3%), hypoproteinemia (1/12, 8.3%), hypoalbuminemia (6/12, 50%,) hypocalcemia (2/12, 16.7%), hyperphosphatemia (9/12, 75%), hyonatremia (7/12, 58.3%), hyperkalemia (3/12, 25%), hypokalemia (5/12, 41.7%) and hypochloremia (4/12, 33.3%) were the common laboratory findings (Table 2). In contrast, of those animals with chronic renal failure, hemoconcentration (3/8, 37.
참고문헌 (13)
Berlyne GM, Hewitt V, Jones H. protein loss in peritoneal dialysis. Lancet 1964; 1: 738-741
Crisp MS, Chew DJ, DiBartola SP, Birchard SJ. Peritoneal dialysis in dogs and cats: 27cases (1976-1987). J Am Vet Med Assoc 1989; 195: 1262-1266.
Dzyban LA, Labato MA, Ross LA. Peritoneal dialysis. In: Kirk’s Current Veterinary Therapy, 13th ed. Philadelphia: Suanders, 2000; 859
Dzyban LA, Labato MA. Peritoneal dialysis: A tool in veterinary critical care. J Vet Emeg Crit Care 2000; 10: 91- 102
Lane IF, Carter LJ, Lappin MR. Peritoneal dialysis: an update on methods and usefulness. In: Kirk’s Current Veterinary Therapy, 11th ed. Philadelphia: Suanders, 1992; 865-870
Nolph KD. Continuous ambulatory peritoneal dialysis as long-term treatment for end-stage renal disease. Am J Kidney Dis 1991; 17: 154-157
Ribot S, Jacobs MG, Frankel HJ. Complications of peritoneal dialysis. Am J Med Sci 1966; 252: 505-517
Ross EA, Mars DR. Peritoneal dialysis: applications in acute and chronic end-stage kidney disease in the dog and cat. Lake Buena Vista: Proceedings of the 15th ACVIM Forum, 1997; 31
Ross EA, Mars DR. Peritoneal diaysis. In: Nephrology, 2nd ed. Baltimore: Williams and Wiikins, 1992; 243-255
Stone RW. A protocol for peritoneal dialysis. J Vet Crit Care 1985; 8: 2
※ AI-Helper는 부적절한 답변을 할 수 있습니다.